NUMELVI is a tablet taken once daily, and it is the first treatment and the only second-generation Janus kinase (JAK) inhibitor designed to treat itch associated with allergic dermatitis, including atopic dermatitis, and to treat the clinical symptoms of atopic dermatitis in dogs. NUMELVI – the new generation of itch relief – is a new product for managing allergic dermatitis in dogs, offering selectivity, safety, and ease. Active Ingredients NUMELVI contains Atinvicitinib. Uses For the treatment of itch associated with allergic dermatitis, including atopic dermatitis in dogs. For the treatment of inflammation and clinical symptoms of atopic dermatitis in dogs.
Expires on March 31, 2029